249 related articles for article (PubMed ID: 30258109)
1. Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition.
Sohn M; Shin S; Yoo JY; Goh Y; Lee IH; Bae YS
Sci Rep; 2018 Sep; 8(1):14379. PubMed ID: 30258109
[TBL] [Abstract][Full Text] [Related]
2. Proprotein convertase subtilisin/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells.
Suh JM; Son Y; Yoo JY; Goh Y; Seidah NG; Lee S; Bae YS
Neoplasia; 2021 Sep; 23(9):993-1001. PubMed ID: 34352405
[TBL] [Abstract][Full Text] [Related]
3. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.
Ruan JS; Liu YP; Zhang L; Yan LG; Fan FT; Shen CS; Wang AY; Zheng SZ; Wang SM; Lu Y
Acta Pharmacol Sin; 2012 Oct; 33(10):1325-31. PubMed ID: 22983392
[TBL] [Abstract][Full Text] [Related]
4. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
5. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
6. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
[TBL] [Abstract][Full Text] [Related]
8. TRPC1-STIM1 activation modulates transforming growth factor β-induced epithelial-to-mesenchymal transition.
Schaar A; Sukumaran P; Sun Y; Dhasarathy A; Singh BB
Oncotarget; 2016 Dec; 7(49):80554-80567. PubMed ID: 27793015
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study of the inhibitory effect and mechanism of B16F10-ESAT-6-gpi/IL-21 vaccine on the pulmonary metastasis in mouse models of melanoma].
He X; Shi W; Zhao F; Wang J; Xu X; Tan Q; Sun Y; Chen D; Dou J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):245-9. PubMed ID: 24989908
[TBL] [Abstract][Full Text] [Related]
10. Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition.
Prasanphanich AF; Arencibia CA; Kemp ML
Free Radic Biol Med; 2014 Nov; 76():1-13. PubMed ID: 25088330
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
12. Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.
Liu J; Qu X; Shao L; Hu Y; Yu X; Lan P; Guo Q; Han Q; Zhang J; Zhang C
Cancer Biol Ther; 2018 Mar; 19(3):160-168. PubMed ID: 29370558
[TBL] [Abstract][Full Text] [Related]
13. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway.
Lee IH; Sohn M; Lim HJ; Yoon S; Oh H; Shin S; Shin JH; Oh SH; Kim J; Lee DK; Noh DY; Bae DS; Seong JK; Bae YS
Oncogene; 2014 Sep; 33(38):4675-84. PubMed ID: 24662814
[TBL] [Abstract][Full Text] [Related]
14. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.
Shi Y; Wang X; Xu Z; He Y; Guo C; He L; Huan C; Cai C; Huang J; Zhang J; Li Y; Zeng C; Zhang X; Wang L; Ke Y; Cheng H
J Biol Chem; 2020 Oct; 295(40):13798-13811. PubMed ID: 32737199
[TBL] [Abstract][Full Text] [Related]
15. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors.
Zhao L; Liu S; Che X; Hou K; Ma Y; Li C; Wen T; Fan Y; Hu X; Liu Y; Qu X
Int J Mol Med; 2015 Sep; 36(3):645-52. PubMed ID: 26133118
[TBL] [Abstract][Full Text] [Related]
16. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.
Wang X; Zhao F; He X; Wang J; Zhang Y; Zhang H; Ni Y; Sun J; Wang X; Dou J
Oncotarget; 2015 May; 6(14):12493-504. PubMed ID: 25895132
[TBL] [Abstract][Full Text] [Related]
17. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
18. Involvement of TGFβ-induced phosphorylation of the PTEN C-terminus on TGFβ-induced acquisition of malignant phenotypes in lung cancer cells.
Aoyama D; Hashimoto N; Sakamoto K; Kohnoh T; Kusunose M; Kimura M; Ogata R; Imaizumi K; Kawabe T; Hasegawa Y
PLoS One; 2013; 8(11):e81133. PubMed ID: 24278390
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
[TBL] [Abstract][Full Text] [Related]
20. Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir.
Wang X; Zhao F; Shi F; He X; Pan M; Wu D; Li M; Zhang Y; Dou J
Biomed Pharmacother; 2016 May; 80():136-144. PubMed ID: 27133050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
